Skip to content
healthcare.dev

Topotecan

NDC 0409-0302, TOPOTECAN, injection, solution, concentrate, from Hospira, Inc..

Product NDC
0409-0302
Status
Listed
Labeler
Hospira, Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA200582
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0409-0302 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPOTECAN HYDROCHLORIDE1 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
0409-0302-01004090302011 VIAL, SINGLE-DOSE in 1 CARTON (0409-0302-01) / 4 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1d4e1cce-c57e-4a8b-be96-f95a2778e221
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0409-0302

Use it

Look up 0409-0302 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0409-0302 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0409-0302. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.